Provectus Biopharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 14 shareholders own 8.16% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
4.41%	Jeffrey Morris	18,500,000	€2.5m	0%	no data
1.58%	Eric Wachter	6,649,298	€881.4k	0%	no data
0.84%	Edward Pershing	3,532,980	€468.3k	0%	no data
0.64%	Bruce Horowitz	2,677,243	€354.9k	0%	no data
0.29%	Heather Raines	1,213,153	€160.8k	0%	no data
0.26%	Dominic Rodrigues	1,077,409	€142.8k	0%	no data
0.048%	John Lacey	200,000	€26.5k	0%	no data
0.035%	Gregory Bailey	145,528	€19.3k	0%	no data
0.024%	Home Federal Bank Of Tennessee, Asset Management Arm	100,000	€13.3k	0%	0.01%
0.012%	Lee, Danner & Bass, Inc.	50,000	€6.6k	0%	no data
0.0063%	Atlas Wealth LLC	26,620	€3.5k	0%	no data
0.0052%	LBMC Investment Advisors, LLC	22,000	€2.9k	0%	no data
0.0048%	Academy Capital Management	20,000	€2.7k	0%	no data
0%	The Huntington Trust Company, National Association	1	€0	0%	no data